• Profile
Close

High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis

Journal of Neuroimmunology Jun 27, 2021

Uzawa A, Akamine H, Kojima Y, et al. - In the present study, the researchers sought to assess the clinical significance of serum interleukin-6 (IL-6) level as a biomarker of disease activity in patients with an anti-acetylcholine receptor (AChR) antibody-positive myasthenia gravis (MG). Serum IL-6 levels were measured in 93 treatment-naïve patients with anti-AChR antibody-positive MG and contrasted with those in 101 controls. Furthermore, correlations between serum IL-6 levels and clinical characteristics were investigated. Findings suggested that IL-6 plays a role in the pathogenesis of anti-AChR antibody-positive MG and might be a therapeutic target in MG.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay